PDCD1 and autoimmune disease: The PD-1/PD-Ligand pathways are major regulators of effector T cell responses in normal and pathologic conditions, including cancer, infectious and autoimmune disease, and have emerged as important targets for cancer immunotherapy (Sharma and Allison, 2015a, Sharma and Allison, 2015b).